Spinal Cord Stimulation Market Demand Size Analysis 2022-2029

Spinal Cord Stimulation Market Demand Size Analysis 2022-2029

Spinal Cord Stimulation Market is segmented By Product Type (Implantable pulse generator, Rechargeable, Non-rechargeable, Radiofrequency system), By Disease Indication (Failed Back Syndrome (FBS), Degenerative Disk Disease (DDD), Complex Regional Pain Syndrome (CRPS), Arachnoiditis, Others), By End-user (Hospitals, Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029

2021-09-21

The key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches along with increased focus on R&D are other ways the leading players improve their market presence.

ABBOTT LABORATORIES

  • Abbott Laboratories (Abbott) develops, manufactures, and markets diagnostic devices, diabetes care, vision technologies, vascular products, and nutrition and animal health products. 
  • The company provides innovative medical devices to fulfill the unmet healthcare needs. 
  • The company provides drug testing products and solutions through its diagnostics segment. 
  • Abbott Core Laboratory offers a complete portfolio of hematology solutions, including automated analyzers, slide-maker stainers, reagents, calibrators and controls for laboratories with diverse testing volumes.
  • Abbott Laboratories operates its business in over 150 countries worldwide.

Boston Scientific Corporation

  • Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices used in a range of interventional medical specialties.
  • The company offers its products by businesses such as Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals.
  • Moreover, it operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. 
  • MedSurg consists of Endoscopy and Urology, and Pelvic Health businesses.
  • The rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses.

Medtronic Plc

  • Medtronic is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. 
  • Their medical technology makes healthcare more efficient and improves people’s lives.
  •  The Company operates in four segments: Cardiac and Vascular Group, Restorative Therapies Group, Minimally Invasive Technologies Group and Diabetes Group. 
  • The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Nevro Corporation

  • Nevro is a medical device company and creator of HF10®, the evidence-based treatment for chronic pain of the trunk and limbs.
  •  The Company develops and commercializes a spinal cord stimulation system for the treatment of chronic pain. Nevro markets its products worldwide.
  • Nevro created a disruption of traditional spinal cord stimulation (SCS) by offering a next-generation approach called HF10 therapy that provides patients with significant pain relief and no paresthesia.
  • The Nevro Senza SCS System for HF10 received CE mark, TGA approval, FDA approval and is commercially available in Europe, Australia, and the United States. 
  • Their SCS systems are now approved to deliver 2-1200 Hz & 10,000 Hz frequencies and the most waveform types in a single product, helping patients to achieve long-term pain relief.

Greatbatch

  • Greatbatch, Inc. is developer and manufacturer of components for implantable medical devices (IMDs) and Electrochem batteries.
  •  The Company’s customers include large multi-national original equipment manufacturers (OEMs). 
  • The Greatbatch Medical segment designs and manufactures medical devices and components primarily for the cardiac rhythm management (CRM), neuromodulation, vascular access and orthopaedic markets.
  • In 2016,Greatbatch Medical & Lake Region Medical® combined and renamed Integer.
  • Integer is the parent company of Greatbatch.

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com

Found it interesting?

Sai Kiran
Sales Manager at DataM Intelligence
Email: [email protected]
Tel: +1 877 441 4866

We have 5000+ marketing reports and serve across 130+ countries